KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q3 2025 value amounting to $1.0 million.

  • Teva Pharmaceutical Industries' Income from Non-Controlling Interests fell 9787.23% to $1.0 million in Q3 2025 from the same period last year, while for Dec 2025 it was $7.0 million, marking a year-over-year increase of 10218.75%. This contributed to the annual value of $7.0 million for FY2025, which is 10218.75% up from last year.
  • Teva Pharmaceutical Industries' Income from Non-Controlling Interests amounted to $1.0 million in Q3 2025, which was down 9787.23% from $6.0 million recorded in Q1 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Income from Non-Controlling Interests ranged from a high of $47.0 million in Q3 2024 and a low of -$280.0 million during Q1 2024
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was $3.0 million (2022), whereas its average is -$21.3 million.
  • Over the last 5 years, Teva Pharmaceutical Industries' Income from Non-Controlling Interests had its largest YoY gain of 48750.0% in 2024, and its largest YoY loss of 155000.0% in 2024.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Income from Non-Controlling Interests stood at $7.0 million in 2021, then plummeted by 557.14% to -$32.0 million in 2022, then soared by 112.5% to $4.0 million in 2023, then plummeted by 1550.0% to -$58.0 million in 2024, then surged by 101.72% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $6.0 million for Q1 2025, and -$58.0 million during Q4 2024.